Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$36,000.00

Mapping Lipid Molecular Species: Advancing High-Sensitivity Lipidomics in Cells and Small Extracellular Vesicles

FY 2024-25

Summary
Small extracellular vesicles (sEVs) are membranous structures secreted by cells that are crucial for intercellular communication. They have excellent potential for investigating biochemical mechanisms, biocompatible nanoparticle engineering, environmental monitoring, and nutritional investigations. However, their small size (30-150 nm), complexity and labile nature pose significant analytical challenges. Lipids are the primary sEV components, making lipidomics - the comprehensive analysis of lipids in a biological sample - a suitable analytical approach. Still, current methods lack sensitivity, coverage, accuracy, and precision. Although lipidomics platforms using mass spectrometry can detect up to 30,000 features, 50-80% remain unidentified. These detectable but unknown compounds represent wasted data and resources that hide the secrets of biochemical mechanisms and compositions. Furthermore, current annotation and quantification accuracies are insufficient, with molar concentration errors reaching 800%. An interdisciplinary approach is necessary to address these issues, combining analytical chemistry, data sciences, and lipid biochemistry. This program's long-term vision is to create innovative lipidomics platforms to fill the current technological gaps in lipid coverage, annotations, and quantification. The developed methods will have a broad range of applications, but this program is mainly centred on unravelling sEV lipid compositions and mechanisms. Over the next five years, I will focus on two specific aims: Specific Aim 1: Develop innovative approaches to enhance lipidomics' coverage, annotation accuracy, and reliability at the detailed molecular species level. I will combine analytical separations, mass spectrometry, and data sciences to create new platforms, including a comprehensive analysis of all lipid species (untargeted) and methods focused on selected lipid classes (semi-targeted). This aim will deliver the Canadian Lipidome Database (CLD), a domestic resource for lipid annotations that will unite an extensive experimental database with an AI-powered annotation prediction system. Specific Aim 2: Investigate the lipidome of sEVs using two human cell lines, HeLa (cervical cancer) and HEK293 (embryonic kidney). I will evaluate lipid alterations related to sEV isolation, culturing conditions, and co-cultures. This in-depth study of sEV lipidomes will open doors to exploring intercellular communication mechanisms and designing biocompatible nanoparticles. The proposed research aims to enhance lipidomics' excellence and feasibility, establishing Canada's leadership in this field. CLD will significantly improve lipid annotations, increasing the accuracy and reliability of investigations. I will initially focus on sEVs from human cells but expect broader applications across various domains, including biochemistry, bioengineering, food sciences, agriculture, microbiology, biotechnology, environmental research, and One Health.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2024-04272
Name nom
Zardini Buzatto, Adriana
Department département
Biological Sciences
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Mapping Lipid Molecular Species: Advancing High-Sensitivity Lipidomics in Cells and Small Extracellular Vesicles
Keywords
lipidomics; analytical chemistry; bioanalytical chemistry; mass spectrometry; high performance liquid chromatography (hplc); separation methods and technologies; analytical method development; extracellular vesicles; lipid extraction; bioinformatics
Application summary
Small extracellular vesicles (sEVs) are membranous structures secreted by cells that are crucial for intercellular communication. They have excellent potential for investigating biochemical mechanisms, biocompatible nanoparticle engineering, environmental monitoring, and nutritional investigations. However, their small size (30-150 nm), complexity and labile nature pose significant analytical challenges. Lipids are the primary sEV components, making lipidomics - the comprehensive analysis of lipids in a biological sample - a suitable analytical approach. Still, current methods lack sensitivity, coverage, accuracy, and precision. Although lipidomics platforms using mass spectrometry can detect up to 30,000 features, 50-80% remain unidentified. These detectable but unknown compounds represent wasted data and resources that hide the secrets of biochemical mechanisms and compositions. Furthermore, current annotation and quantification accuracies are insufficient, with molar concentration errors reaching 800%. An interdisciplinary approach is necessary to address these issues, combining analytical chemistry, data sciences, and lipid biochemistry. This program's long-term vision is to create innovative lipidomics platforms to fill the current technological gaps in lipid coverage, annotations, and quantification. The developed methods will have a broad range of applications, but this program is mainly centred on unravelling sEV lipid compositions and mechanisms. Over the next five years, I will focus on two specific aims: Specific Aim 1: Develop innovative approaches to enhance lipidomics' coverage, annotation accuracy, and reliability at the detailed molecular species level. I will combine analytical separations, mass spectrometry, and data sciences to create new platforms, including a comprehensive analysis of all lipid species (untargeted) and methods focused on selected lipid classes (semi-targeted). This aim will deliver the Canadian Lipidome Database (CLD), a domestic resource for lipid annotations that will unite an extensive experimental database with an AI-powered annotation prediction system. Specific Aim 2: Investigate the lipidome of sEVs using two human cell lines, HeLa (cervical cancer) and HEK293 (embryonic kidney). I will evaluate lipid alterations related to sEV isolation, culturing conditions, and co-cultures. This in-depth study of sEV lipidomes will open doors to exploring intercellular communication mechanisms and designing biocompatible nanoparticles. The proposed research aims to enhance lipidomics' excellence and feasibility, establishing Canada's leadership in this field. CLD will significantly improve lipid annotations, increasing the accuracy and reliability of investigations. I will initially focus on sEVs from human cells but expect broader applications across various domains, including biochemistry, bioengineering, food sciences, agriculture, microbiology, biotechnology, environmental research, and One Health.